AstraZeneca Inc said on Monday that its antibody-mixture drug, the first protective dose other than vaccines against Covid-19, has achieved its main goals in last-stage trials by helping reduce severe cases of Covid-19 infection or death
Tags AstraZeneca coronavirus COVID-19
Check Also
Tesla Stock Popped Ahead of Q2 Deliveries, Here is Why
Tesla stocks have been on the comeback trail recently, and that continued on the first …